Dissolution testing using continuous multicomponent UV analysis to correct for excipient interferenceANDERSON, N. H; JOHNSTON, D; VOJVODIC, P. R et al.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 987-989, issn 0731-7085, 3 p.Conference Paper

Factors influencing drug absorption and drug availabilityHOENER, B.-A; BENET, L. Z.Drugs and the pharmaceutical sciences. 1990, Vol 40, pp 143-180, issn 0360-2583, 38 p.Article

Coating of solid dosage formsBODMEIER, Roland.European journal of pharmaceutics and biopharmaceutics. 1999, Vol 47, Num 1, issn 0939-6411, 90 p.Serial Issue

Spectrophotometric determination of tetracycline and oxytetracycline in pharmaceutical preparationsEMARA, K. M; ASKAL, H. F; SALEH, G. A et al.Talanta (Oxford). 1991, Vol 38, Num 11, pp 1219-1221, issn 0039-9140Article

The evolution of synthetic oral drug propertiesPROUDFOOT, John R.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 4, pp 1087-1090, issn 0960-894X, 4 p.Article

Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquidsALLEN, L. V; ERICKSON, M. A.American journal of health-system pharmacy. 1996, Vol 53, Num 18, pp 2179-2184, issn 1079-2082Article

An orally effective peripheral dopamine prodrug : docarpamine (TA-870)NISHIYAMA, S; YOSHIKAWA, M; YAMAGUCHI, I et al.Cardiovascular drug reviews (Print). 1991, Vol 10, Num 1, pp 101-116, issn 0897-5957Article

Symposium on tablet technology, Stockholm, February 24-27, 1987Acta pharmaceutica suecica. 1987, Vol 24, Num 2, issn 0001-6675, 87 p.Conference Proceedings

Formes solides orales = Oral solid formJournal de pharmacie de Belgique. 1996, Vol 51, Num 5, pp 239-244, issn 0047-2166Article

Bestimmung der Quellungsgeschwindigkeit von Komprimaten mit hydrophilen Gelbildnern = Mesure de la vitesse de gonflement de comprimés contenant des agents hydrophiles formant des gels = Determination of swelling speed of tablets with hydrophilous gel-forming agentsSÜSS, W.Pharmazie. 1986, Vol 41, Num 11, issn 0031-7144, 816Article

New materials for novel excipientsFLORENCE, A.Manufacturing chemist (London. 1981). 1998, Vol 69, Num 5, pp 27-29, issn 0262-4230, 2 p.Article

Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquidsALLEN, L. V; ERICKSON, M. A.American journal of health-system pharmacy. 1996, Vol 53, Num 17, pp 2073-2078, issn 1079-2082Article

Carbocistéisne = CarbocisteineLa Revue Prescrire. 1996, Vol 16, Num 163, issn 0247-7750, p. 452Article

Keimwachstum in Zuckerlösungen : Untersuchungen zu limitierenden Faktoren = Microbial growth in sugar solutions. Investigations on limiting factorsLEHNER, S. J; FURKERT, F; MÜLLER, B. W et al.Pharmazeutische Industrie. 1994, Vol 56, Num 10, pp 911-914, issn 0031-711XArticle

Compaction of multiparticulate oral dosage formsCELIK, M.Drugs and the pharmaceutical sciences. 1994, Vol 65, pp 181-215, issn 0360-2583Article

Effects of oral hypoglycaemic agents on platelet functionsOZAKI, Y; YATOMI, Y; KUME, S et al.Biochemical pharmacology. 1992, Vol 44, Num 4, pp 687-691, issn 0006-2952Article

Design and preparation of pulsatile release tablet as a new oral drug delivery systemISHINO, R; YOSHINO, H; HIRAKAWA, Y et al.Chemical and pharmaceutical bulletin. 1992, Vol 40, Num 11, pp 3036-3041, issn 0009-2363Article

¹H-NMR spectroscopic assay method for metoclopramide hydrochloride in tablets and injectionsHANNA, G. M; LAU-CAM, C. A.Drug development and industrial pharmacy. 1991, Vol 17, Num 7, pp 975-984, issn 0363-9045, 10 p.Article

Comparison of the bioavailability of two slow release preparations of disopyramideBOGAERT, M. G; BELPAIRE, F; DE WILDE, G et al.European journal of clinical pharmacology. 1991, Vol 40, Num 6, pp 629-630, issn 0031-6970, 2 p.Article

Comparative pH-gradient dissolution of several oral dosage forms of ironIAN BORST, S.Drug development and industrial pharmacy. 1991, Vol 17, Num 17, pp 2333-2339, issn 0363-9045Article

Entwicklung fester peroraler Arzneiformen mit Hilfe multivariater mathematischer Verfahren. III, Die Modellierung eines Rezepturproblems = Development of solid oral dosage forms by means of multivariate mathematical techniquesPODCZECK, F; WENZEL, U.Pharmazeutische Industrie. 1990, Vol 52, Num 4, pp 496-500, issn 0031-711X, 5 p.Article

Development of oral liquid dosage forms of acetazolamidePARASRAMPURIA, J; DAS GUPTA, V.Journal of pharmaceutical sciences. 1990, Vol 79, Num 9, pp 835-836, issn 0022-3549, 2 p.Article

Renin inhibitors designed on the basis of angiotensinogen transition stateIIZUKA, K; KAMIJO, T; HARADA, H et al.Journal of pharmacobio-dynamics. 1989, Vol 12, Num 6, issn 0386-846X, S 132 [1 p.]Conference Paper

Relationships between oral sensory feedback skills and adaptation to delayed auditory feedbackATTANASIO, J. S.Journal of communication disorders. 1987, Vol 20, Num 2, pp 391-402, issn 0021-9924Article

Bioavailability of sustained release acetazolamideKELLY, R. G.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 11, pp 863-864, issn 0022-3573Article